tirzepatide vs metformin + for Weight Loss: Safety & Evidence – PlexusDx Tirzepatide vs Metformin - Face

Sanofi Industry Developments July 2026: Novo Nordisk received CDSCO approval for Wegovy (semaglutide) as the first and only GLP-1 receptor agonist approved in India for noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis, expanding the drug's indication beyond weight management and type 2 diabetes

*Correspondence: Dion R

Some people find that planning meals in advance eliminates the decision fatigue that leads to poor choices when appetite returns unpredictably

ALL BIOCARE NEW BioCare Products Antioxidants and Immune Support BioMulsion Cardiovascular Formulations Children's Health Digestive Enzymes Energy Formulations Fatty Acids Female Health Gastrointestinal Liver and Elimination Male Health Minerals Multi-nutrients Musculoskeletal Formulations Nervous System Formulations Nutrisorb Liquids Probiotics Vitamins Vitasorb Liquid Vitamins Lamberts Healthcare

Protects against Tetanus, caused by Clostridium tetani bacteria